Top Back to top

Haploidentical stem cell transplantation using PTCY for children with acute leukemia

Paediatric Diseases Working Party (PDWP)
Study number:
Short title:
PT-Cy based haploidentical HSCT for Acute Leukemia
Study status:
Deadline for data collection:
Study design:
Retrospective registry based analysis
Primary objective:
Primary end point:
Leukemia-free survival (LFS)

Secondary end points are:
Haematopoietic recovery, grades II-IV and grade III-IV GVHD, chronic GVHD, transplantation-related mortality, relapse, GRFS and OS
Key inclusion criteria:
1) Patient age less/= than 18 years
2) Patient diagnosed with either ALL or AML
3) Patient who underwent a first allograft between 2010 and 2016 included.
4) Patient which received unmanipulated (non TCD) haploidentical stem cell transplantation
5) Post-transplant cyclophosphamide as GVHD prophylaxis

Principal investigator:
Annalisa Ruggeri
Principal investigator email:
EBMT Study coordinator:
Arnaud Dalissier
Study coordinator email: